文献速递母胎医学

拷贝数变异的不确定性:妊娠决策与临床随访

The uncertainty of copy number variants: pregnancy decisions and clinical follow-up.
PubMed 文献 · Am J Obstet Gynecol · 2023-01-27

在单一生前诊断单位中,对8030例胎儿行拷贝数变异测序,检出139例按2015年美国医学遗传学与基因组学学会指南归类为意义不明变异(VUS)的妊娠;多数(78%)为遗传性且携带父母无病,多数遗传性VUS妊娠继续,多数新发VUS妊娠终止;113例活产中仅5例出现与原始VUS无明显关联的表型。

要点

  • 胎儿超声异常严重程度结合亲源检测结果是妊娠管理决策的关键驱动因素。
  • 113例活产随访中仅5例出现与原始VUS无明显关联的表型,多数VUS在出生结局上呈良性。
  • 按2020年美国医学遗传学与基因组学学会指南重新分析,24例VUS状态改变(15例良性、9例致病),两版指南VUS评分不一致率为17%。

核心结论

  • 胎儿超声异常严重程度结合亲源检测结果是患者妊娠管理决策的关键驱动因素。
  • 根据继续妊娠的出生结局,多数VUS在性质上呈明显良性,且不良疾病结局风险可能较低。
  • 2015年与2020年美国医学遗传学与基因组学学会指南对VUS评分的不一致率为17%,提示预测真实致病性仍存在困难。
  • 随着对人群拷贝数变异多态性知识的增加以及对替代遗传原因的更完整评估,接受产前评估的患者在发现胎儿VUS时应感到较少焦虑。

研究设计与样本

  • 在单一生前诊断单位中,对8030例具有意外无创检查发现的胎儿行前瞻性拷贝数变异测序染色体检测。
  • 检出139例按当时适用的2015年美国医学遗传学与基因组学学会指南归类为VUS的拷贝数变异。
  • 随后行亲源检测以确定拷贝数变异为遗传性还是新发。
  • 所有夫妇均接受专门遗传咨询以协助妊娠管理决策。
  • 对达到足月的继续妊娠,新生儿在0至10月龄和/或2至4岁龄时接受临床评估以寻找任何疾病证据。

主要发现

  • 139例VUS中多数(78%)为遗传性,且携带父母无疾病证据。
  • 基于主要超声发现结合无创产前筛查结果,多数遗传性VUS妊娠继续,而多数新发VUS妊娠终止。
  • 113例活产临床随访中,仅5例显示任何与原始VUS无明显关联的表型证据。
  • 用2020年美国医学遗传学与基因组学学会指南前瞻性重新分析139例VUS,24例VUS状态改变,其中15例重新分类为良性、9例为致病性。
  • 5例出生时携带被重新分类为致病性的遗传性VUS的儿童,临床随访中未显示疾病表型证据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Next-generation sequencing for copy number variants is often used as a follow-up investigation of unusual fetal ultrasound results and is capable of detecting copy number variations with a resolution of ∼0.1 Mb. In a prenatal setting, observation and subsequent management of pregnancies with a fetal variant of uncertain significance remains problematic for counseling. OBJECTIVE: This study aimed to follow the decision-making processes in pregnancies with a fetal variant of uncertain significance and prospectively assess copy number variation interpretations and implications under the newer 2020 American College of Medical Genetics and Genomics guidelines. STUDY DESIGN: In a single prenatal unit, prospective chromosome testing using copy number variation sequencing for 8030 fetuses with unexpected noninvasive findings identified 139 pregnancies with a copy number variation classified as a variant of uncertain significance according to the 2015 American College of Medical Genetics and Genomics guidelines current at the time. Parent-of-origin testing was subsequently performed to determine if the copy number variation was inherited or de novo. All couples were offered specialized genetic counseling to assist in pregnancy management decisions. For the continued pregnancies that reached term, newborns were clinically assessed for evidence of any disease at 0 to 10 months and/or at 2 to 4 years of age. RESULTS: Of the 139 variants of uncertain significance found, most (78%) were inherited with no evidence of disease in the carrier parent. On the basis of primary ultrasound findings combined with results from noninvasive prenatal screening tests, most inherited variant of uncertain significance pregnancies were continued, whereas most pregnancies involving de novo variants of uncertain significance were terminated. From clinical follow-up of the 113 live births, only 5 showed any evidence of a phenotype that was not apparently related to the original variant of uncertain significance. Prospective reanalysis of the 139 variants of uncertain significance using recent 2020 American College of Medical Genetics and Genomics guidelines changed the status of 24 variants of uncertain significance, with 15 reclassified as benign and 9 as pathogenic. However, the 5 children born with an inherited variant of uncertain significance reclassified as pathogenic showed no evidence of a disease phenotype on clinical follow-up. CONCLUSION: The severity of fetal ultrasound findings combined with results from parent-of-origin testing were the key drivers in pregnancy management decisions for patients. According to birth outcomes from continued pregnancies, most variants of uncertain significance proved to be apparently benign in nature and potentially of low risk of adverse disease outcome. There was a discordance rate of 17% for variant of uncertain significance scoring between the 2015 and 2020 American College of Medical Genetics and Genomics guidelines for defining a variant of uncertain significance, suggesting that difficulties remain for predicting true pathogenicity. Nonetheless, with increasing knowledge of population copy number variation polymorphisms, and a more complete assessment for alternative genetic causes, patients having prenatal assessments should feel less anxious when a fetal variant of uncertain significance is identified.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Shi P, Liang H, Hou Y, et al. The uncertainty of copy number variants: pregnancy decisions and clinical follow-up. Am J Obstet Gynecol. 2023. PMID: 36716986. doi:10.1016/j.ajog.2023.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。